HOB Biotech Group Corp Ltd (688656) — Cash Flow Reinvestment Rate
HOB Biotech Group Corp Ltd (688656) has a Cash Flow Reinvestment Rate of 0.56x as of December 2025, reinvesting CN¥8.50 Million (capex CN¥8.50 Million ) from operating cash flow of CN¥15.28 Million. Check HOB Biotech Group Corp Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HOB Biotech Group Corp Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for HOB Biotech Group Corp Ltd across 10 annual periods. Explore HOB Biotech Group Corp Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for HOB Biotech Group Corp Ltd (2016–2025)
Year-by-year capital reinvestment analysis for HOB Biotech Group Corp Ltd. For live market cap and broader valuation context, see HOB Biotech Group Corp Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.01x | CN¥73.90 Million | CN¥72.94 Million | CN¥73.90 Million | ▼ -34.4% |
| 2024 | 1.55x | CN¥156.43 Million | CN¥101.22 Million | CN¥155.37 Million | ▼ -27.1% |
| 2023 | 2.12x | CN¥217.58 Million | CN¥102.69 Million | CN¥178.03 Million | ▼ -78.1% |
| 2022 | 9.67x | CN¥564.07 Million | CN¥58.31 Million | CN¥220.21 Million | ▲ +214.6% |
| 2021 | 3.08x | CN¥322.28 Million | CN¥104.79 Million | CN¥167.89 Million | ▲ +94.5% |
| 2020 | 1.58x | CN¥92.04 Million | CN¥58.22 Million | CN¥57.01 Million | ▲ +58.1% |
| 2019 | 1.00x | CN¥68.55 Million | CN¥68.57 Million | CN¥34.80 Million | ▲ +74.4% |
| 2018 | 0.57x | CN¥26.66 Million | CN¥46.51 Million | CN¥26.66 Million | ▼ -38.7% |
| 2017 | 0.94x | CN¥20.82 Million | CN¥22.26 Million | CN¥20.82 Million | ▼ -65.0% |
| 2016 | 2.67x | CN¥17.15 Million | CN¥6.42 Million | CN¥17.15 Million | — |